These compounds may interact with:
Cyclin-dependent kinase 6
Potentially involved in: microcephaly; acquired metabolic disease; rheumatoid arthritis; cancer; ectopic tissue; chromosome aberrations; glioblastoma; leukemia, myelocytic, acute; mammary neoplasms, experimental; medulloblastoma; mental retardation; mild mental retardation; severe mental retardation (i.q. 20-34); vesico-ureteral reflux; hyperreflexia; agenesis of corpus callosum; chloracne; unilateral agenesis of kidney; pachygyria; malignant mesothelioma
Disease data sourced from Pharos.